Gene · 11096
Papers3,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CARMA3 Drives NF-κB Activation and Promotes Intervertebral Disc Degeneration: Involvement of CARMA3-BCL10-MALT1 Signalosome. | Inflammation | 2024 | 38607566 | PubTator, text mining | PubMed |
| Elevated glucose promotes MMP13 and ADAMTS5 production by osteoarthritic chondrocytes under oxygenated but not hypoxic conditions. | J Cell Physiol | 2024 | 38595042 | PubTator, text mining | PubMed |
| Gubi Zhitong formula alleviates osteoarthritis in vitro and in vivo via regulating BNIP3L-mediated mitophagy. | Phytomedicine | 2024 | 38581801 | PubTator, text mining | PubMed |
| TMF inhibits extracellular matrix degradation by regulating the C/EBPβ/ADAMTS5 signaling pathway in osteoarthritis. | Biomed Pharmacother | 2024 | 38554527 | PubTator, text mining | PubMed |
| ADAMTS5 Promotes Permeability of the Blood-Brain Barrier during Treponema pallidum Subspecies pallidum Invading the Central Nervous System. | ACS Infect Dis | 2024 | 38536197 | PubTator, text mining | PubMed |
| Inhibition of the MALT1-LPCAT3 axis protects cartilage degeneration and osteoarthritis. | Cell Commun Signal | 2024 | 38519981 | PubTator, text mining | PubMed |
| A prognostic and immune related risk model based on zinc homeostasis in hepatocellular carcinoma. | iScience | 2024 | 38510110 | PubTator, text mining | PubMed |
| Bisdemethoxycurcumin, a curcumin, protects chondrocytes, and reduces cartilage inflammation via the NRF2/HO-1/NLRP3 pathway. | Immun Inflamm Dis | 2024 | 38411358 | PubTator, text mining | PubMed |
| Combining Mendelian Randomization Analysis and 3D-QSAR to Investigate the Effectiveness of a New Series of Hydroxyquinolines in Osteoarthritis. | Curr Med Chem | 2024 | 38385247 | PubTator, text mining | PubMed |
| Sinapine thiocyanate alleviates intervertebral disc degeneration by not regulating JAK1/STAT3/NLRP3 signal pathway. | Adv Clin Exp Med | 2024 | 38348966 | PubTator, text mining | PubMed |
| BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 Inhibitor. | J Med Chem | 2024 | 38348661 | PubTator, text mining | PubMed |
| Inhibitory Effect of a Tankyrase Inhibitor on Mechanical Stress-Induced Protease Expression in Human Articular Chondrocytes. | Int J Mol Sci | 2024 | 38338721 | PubTator, text mining | PubMed |
Safety, Tolerability, and Pharmacodynamics of the ADAMTS-5 Nanobody M6495: Two Phase 1, Single-Center, Double-Blind, Randomized, Placebo-Controlled Studies in Healthy Subjects and Patients With Osteoarthritis. | ACR Open Rheumatol | 2024 | 38311369 | PubTator, text mining | PubMed |
| 5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPARγ axis. | Nat Commun | 2024 | 38310093 | PubTator, text mining | PubMed |
| Inhibition of HOXD11 promotes cartilage degradation and induces osteoarthritis development. | J Orthop Surg Res | 2024 | 38308324 | PubTator, text mining | PubMed |
| Proteome and phospholipidome interrelationship of synovial fluid-derived extracellular vesicles in equine osteoarthritis: An exploratory 'multi-omics' study to identify composite biomarkers. | Biochem Biophys Rep | 2024 | 38298208 | PubTator, text mining | PubMed |
| [Xinfeng Capsule alleviates interleukin-1β-induced chondrocyte inflammation and extracellular matrix degradation by regulating the miR-502-5p/TRAF2/NF-κB axis]. | Nan Fang Yi Ke Da Xue Xue Bao | 2024 | 38293982 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-derived exosomes as a promising cell-free therapy for knee osteoarthritis. | Front Bioeng Biotechnol | 2024 | 38292826 | PubTator, text mining | PubMed |
| Osteoarthritis versus psoriasis arthritis: Physiopathology, cellular signaling, and therapeutic strategies. | Genes Dis | 2024 | 38292181 | PubTator, text mining | PubMed |
| Cyclic increase in the ADAMTS1-L1CAM-EGFR axis promotes the EMT and cervical lymph node metastasis of oral squamous cell carcinoma. | Cell Death Dis | 2024 | 38263290 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11096/papers?page=11